<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Pediatr</journal-id>
      <journal-id journal-id-type="iso-abbrev">Eur. J. Pediatr</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Pediatrics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0340-6199</issn>
      <issn pub-type="epub">1432-1076</issn>
      <publisher>
        <publisher-name>Springer Berlin Heidelberg</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24221606</article-id>
      <article-id pub-id-type="pmc">3951960</article-id>
      <article-id pub-id-type="publisher-id">2199</article-id>
      <article-id pub-id-type="doi">10.1007/s00431-013-2199-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Okamoto</surname>
            <given-names>Takayuki</given-names>
          </name>
          <address>
            <phone>+81-11-7065954</phone>
            <fax>+81-11-7067898</fax>
            <email>okamon@med.hokudai.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sato</surname>
            <given-names>Yasuyuki</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamazaki</surname>
            <given-names>Takeshi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hayashi</surname>
            <given-names>Asako</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Pediatrics, Hokkaido University Graduate School of Medicine, N15, W7, Sapporo, 060-8638 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>11</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>13</day>
        <month>11</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2014</year>
      </pub-date>
      <volume>173</volume>
      <issue>4</issue>
      <fpage>533</fpage>
      <lpage>536</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>10</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2013</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Common pathogens of clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) are viruses, such as influenza virus. However, bacteria are rare pathogens for MERS. We report the first patient with MERS associated with febrile urinary tract infection. A 16-year-old lupus patient was admitted to our hospital. She had fever, headache, vomiting, and right back pain. Urinary analysis showed leukocyturia, and urinary culture identified <italic>Klebsiella pneumoniae</italic>. Cerebrospinal fluid examination and brain single-photon emission computed tomography showed no abnormalities. Therefore, she was diagnosed with febrile urinary tract infection. For further examinations, 99mTc-dimercaptosuccinic acid renal scintigraphy showed right cortical defects, and a voiding cystourethrogram demonstrated right vesicoureteral reflux (grade II). Therefore, she was diagnosed with right pyelonephritis. Although treatment with antibiotics administered intravenously improved the fever, laboratory findings, and right back pain, she had prolonged headaches, nausea, and vomiting. T2-weighted, diffusion-weighted, and fluid attenuated inversion recovery images in brain magnetic resonance imaging showed high intensity lesions in the splenium of the corpus callosum, which completely disappeared 1&#xA0;week later. These results were compatible with MERS. To the best of our knowledge, our patient is the first patient who showed clinical features of MERS associated with febrile urinary tract infection. <italic>Conclusion</italic>: In patients with pyelonephritis and an atypical clinical course, such as prolonged headache, nausea, vomiting, and neurological disorders, the possibility of MERS should be considered.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Bacteria</kwd>
        <kwd>Febrile urinary tract infection</kwd>
        <kwd>MERS</kwd>
        <kwd>Pyelonephritis</kwd>
        <kwd>Systemic lupus erythematosus</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag Berlin Heidelberg 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is characterized by magnetic resonance imaging (MRI) of a reversible isolated lesion with transiently reduced diffusion in the splenium of the corpus callosum [<xref ref-type="bibr" rid="CR10">10</xref>]. The most common clinical manifestation is a neurological disorder, such as delirious behavior, consciousness disturbance, and seizures. Most patients with MERS clinically recover completely within 1&#xA0;month [<xref ref-type="bibr" rid="CR11">11</xref>]. Influenza virus types A and B are the most common pathogens of MERS. However, bacterial infection has also been reported as pathogens in a few patients with MERS and not in patients with other classifications of acute encephalopathy, such as acute necrotizing encephalopathy and acute encephalopathy with biphasic seizures and late reduced diffusion [<xref ref-type="bibr" rid="CR5">5</xref>]. We report here the first patient with MERS associated with febrile urinary tract infection.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>A 15-year-old Japanese girl was admitted to the hospital with severe periorbital and pedal edema. She also had a butterfly shadow, oral ulcer, and joint pain. A peripheral blood examination showed thrombocytopenia (platelets, 66&#x2009;&#xD7;&#x2009;10<sup>9</sup>/l), hypoproteinemia (serum total protein, 33&#xA0;g/l), hypoalbuminemia (serum albumin, 6&#xA0;g/l), and hypercholesterolemia (total cholesterol, 13&#xA0;mmol/l). Her serum creatinine level was normal (41.5&#xA0;&#x3BC;mol/l). Immunological studies were positive for anti-nuclear antibody with a titer of 1:640 in a peripheral pattern, anti-smooth muscle antibody of 0.22&#xA0;U/l (normal range, 0.0&#x2013;0.0059&#xA0;U/l), anti-U1 ribonucleic protein antibody of 0.15&#xA0;U/l (normal range, 0.0&#x2013;0.012&#xA0;U/l), and anti-single-stranded DNA antibody of 0.035&#xA0;U/l (normal range, 0&#x2013;0.025&#xA0;U/l). Serum complement levels were low, with C3 of 0.49&#xA0;g/l (normal range, 0.86&#x2013;1.6&#xA0;g/l), C4 of 0.1&#xA0;g/l (normal range, 0.17&#x2013;0.45&#xA0;g/l), and CH50 of 22.3&#xA0;kU/l (normal range, 31.5&#x2013;48.4&#xA0;kU/l). Sediment contained 20&#x2013;29 red blood cells and cellular casts per high-power field, and urinalysis showed proteinuria at a concentration of 34,010&#xA0;g/l and urinary protein to creatinine ratio of 27&#xA0;g/gCr. Based on these findings, she was diagnosed with systemic lupus erythematosus (SLE) with nephrotic syndrome. Renal biopsy findings showed a minor glomerular abnormality under light microscopy. By immunofluorescence study, granular depositions of IgG and C3 along the peripheral capillaries were observed, and electron microscopy showed subepithelial deposits. With prednisolone and tacrolimus, she achieved complete remission after 8&#xA0;months.</p>
      <p>At the age of 16&#xA0;years, the patient had fever, headache, vomiting, and right back pain. One day later, she had chills and delirious behavior followed by consciousness disturbance. On admission, the patient was awake but appeared severely ill owing to malaise and dehydration. Her blood pressure was 87/45&#xA0;mmHg, pulse was 89 beats per minute, temperature was 39.5&#xA0;&#xB0;C, and oxygen saturation was 98&#xA0;% while she was breathing ambient air. Her abdominal pain was localized to the right back region, and costovertebral angle tenderness was positive. Peripheral blood analysis showed leukocytosis (white blood cell count, 18&#x2009;&#xD7;&#x2009;10<sup>9</sup>/l), an elevated C-reactive protein level of 0.17&#xA0;g/l (normal range, 0.0&#x2013;0.0039&#xA0;g/l), and serum creatinine level of 78.6&#xA0;&#x3BC;mol/l. Complement levels were normal. Urinary sediments contained 10&#x2013;19 white cells, and urinary culture was positive for <italic>Klebsiella pneumoniae</italic>. Cerebrospinal fluid (CSF) examination showed no abnormalities, and cultures of blood and CSF were negative. In addition, brain single-photon emission computed tomography showed no abnormalities. Therefore, it was thought that flaring of lupus was unlikely, and she was diagnosed with febrile urinary tract infection. Further examinations, including a voiding cystourethrogram (VCUG) and 99mTc-dimercaptosuccinic acid (DMSA) renal scintigraphy, were performed. VCUG showed right vesicoureteral reflux (grade II), and 99mTc-DMSA scintigraphy showed right cortical defects. These results were compatible with right pyelonephritis. Thereafter, treatment with intravenous antibiotics gradually improved signs and symptoms, such as fever, laboratory findings, and right back pain, but she had prolonged headaches, nausea, and vomiting. Therefore, further examinations were performed. As a result, T2-weighted, diffusion-weighted, and fluid attenuated inversion recovery images in brain MRI showed high intensity lesions in the splenium of the corpus callosum on the third hospital day, which completely disappeared 1&#xA0;week later (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). At the same time, headaches, nausea, and vomiting also gradually improved. These typical findings of MRI and clinical features were compatible with MERS.<fig id="Fig1"><label>Fig. 1</label><caption><p>MRI findings of a 16-year-old girl with MERS associated with a febrile urinary tract infection. <bold>a</bold> On the third hospital day, a high signal lesion was observed in the splenium of the corpus callosum as shown by FLAIR MRI (<italic>white arrows</italic>). <bold>b</bold> On the tenth hospital day, the splenial lesion had completely disappeared. <italic>FLAIR</italic> fluid attenuated inversion recovery, <italic>MRI</italic> magnetic resonance imaging, <italic>MERS</italic> clinically mild encephalitis/encephalopathy with a reversible splenial lesion</p></caption><graphic xlink:href="431_2013_2199_Fig1_HTML" id="MO1"/></fig></p>
      <p>At the age of 17&#xA0;years, the patient has not had recurrence of MERS with sustained remission of lupus.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>To the best of our knowledge, our patient is the first patient who showed clinical features of MERS associated with a febrile urinary tract infection. Furthermore, this report is also the first to show an association between MERS and <italic>K.&#x2009;pneumonia</italic> infection. The major pathogens of MERS are viruses, such as influenza virus (A and B), mumps virus, adenovirus, and rotavirus (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). However, bacteria are also known as pathogens, which account for 3.3&#xA0;% of all causes of MERS [<xref ref-type="bibr" rid="CR5">5</xref>]. Streptococci and <italic>Escherichia coli</italic> have been reported as bacterial pathogens of MERS [<xref ref-type="bibr" rid="CR11">11</xref>]. Because bacterial pathogens have not been identified in acute necrotizing encephalopathy and acute encephalopathy with biphasic seizures and late reduced diffusion cases, further research on bacterial pathogens of MERS is required for understanding the etiology and pathogenesis of MERS.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Pathogens of clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in the literature</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Authors</th><th>No. of patients</th><th>Pathogens of MERS in the literature (no. of patients)</th></tr></thead><tbody><tr><td>Hoshino et al. [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td>153</td><td>Influenza (53), rotavirus (18), mumps virus (6), HHV-6 (3), bacterial infection (5)</td></tr><tr><td>Takanashi et al. [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td>54</td><td>Unknown (22), influenza A/B (6/4), mumps virus (4), adenovirus (3), rotavirus (3), streptococcus (3), <italic>Escherichia coli</italic> (3)</td></tr><tr><td>Tada et al. [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td>15</td><td>Unknown (10), influenza A (1), adenovirus (1), mumps virus (1), VZV virus (1)</td></tr><tr><td>Bulakbasi et al. [<xref ref-type="bibr" rid="CR1">1</xref>]</td><td>5</td><td>Influenza A (5)</td></tr><tr><td>Ganapathy et al. [<xref ref-type="bibr" rid="CR3">3</xref>]</td><td>2</td><td>Influenza B (2)</td></tr><tr><td>Takanashi et al. [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td>4</td><td>Kawasaki disease (4)</td></tr></tbody></table></table-wrap></p>
      <p>About the pathogenesis of MERS, there are several hypotheses such as intramyelinic edema, hyponatremia, axonal damage, and oxidative stress [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. However, the exact reason for the development of MERS in patients with bacterial infection, as well as our patient, is unknown. Serum proinflammatory cytokines, including interleukin (IL)-1&#x3B2;, IL-6, and IL-8, and tumor necrosis factor-alpha are elevated in patients with acute pyelonephritis [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], and Kawasaki disease, by which MERS is also complicated [<xref ref-type="bibr" rid="CR13">13</xref>]. Therefore, activation of the immune system is likely to be associated with the pathogenesis of MERS. Although our patient did not appear to have flaring of lupus, lupus was possibly associated with the pathogenesis of MERS in our patient because the pathogenesis of SLE also appears to be associated with activation of the immune system and oxidative stress [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Because of the prolonged headaches, nausea, and vomiting, further examinations were carried out following detection of MERS in our patient. In patients with acute pyelonephritis, clinical findings included varied gastrointestinal signs and symptoms, such as diarrhea, vomiting, and nausea [<xref ref-type="bibr" rid="CR7">7</xref>]. Furthermore, neurological manifestations, such as irritability and seizures, are also possible clinical findings in pyelonephritis [<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, at the onset, it is difficult to determine whether there are typical clinical findings in pyelonephritis or complications of MERS in patients with pyelonephritis. However, if gastrointestinal and neurological features are prolonged after improving pyelonephritis, clinicians should consider the possibility of MERS.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <def-list>
        <def-list>
          <title>List of abbreviations</title>
          <def-item>
            <term>MERS</term>
            <def>
              <p>clinically mild encephalitis/encephalopathy with a reversible splenial lesion</p>
            </def>
          </def-item>
          <def-item>
            <term>MRI</term>
            <def>
              <p>magnetic resonance imaging</p>
            </def>
          </def-item>
          <def-item>
            <term>SLE</term>
            <def>
              <p>systemic lupus erythematosus</p>
            </def>
          </def-item>
          <def-item>
            <term>CSF</term>
            <def>
              <p>cerebrospinal fluid</p>
            </def>
          </def-item>
          <def-item>
            <term>VCUG</term>
            <def>
              <p>voiding cystourethrogram</p>
            </def>
          </def-item>
          <def-item>
            <term>DMSA</term>
            <def>
              <p>dimercaptosuccinic acid</p>
            </def>
          </def-item>
          <def-item>
            <term>IL</term>
            <def>
              <p>interleukin</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <ack>
      <p>We would like to thank Dr. Kohsuke Kudo and Dr. Hideaki Shiraishi for their contribution to diagnosis and management of our patient.</p>
      <sec id="d30e487">
        <title>Conflict of interest</title>
        <p>The authors declare no conflict of interest.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">Bulakbasi N, Kocaoglu M, Tayfun C, Ucoz T (2006) Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 27(9):1983&#x2013;1986</mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Craft</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The pathogenesis of systemic lupus erythematosus&#x2014;an update</article-title>
          <source>Curr Opin Immunol</source>
          <year>2012</year>
          <volume>24</volume>
          <issue>6</issue>
          <fpage>651</fpage>
          <lpage>657</lpage>
          <pub-id pub-id-type="doi">10.1016/j.coi.2012.10.004</pub-id>
          <pub-id pub-id-type="pmid">23131610</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="other">Ganapathy S, Ey EH, Wolfson BJ, Khan N (2008) Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis. Pediatr Radiol 38(11):1243&#x2013;1245</mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gurgoze</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Akarsu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yilmaz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Godekmerdan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Akca</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ciftci</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Aygun</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis</article-title>
          <source>Pediatr Nephrol</source>
          <year>2005</year>
          <volume>20</volume>
          <issue>10</issue>
          <fpage>1445</fpage>
          <lpage>1448</lpage>
          <pub-id pub-id-type="doi">10.1007/s00467-005-1941-6</pub-id>
          <pub-id pub-id-type="pmid">16079986</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoshino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Okumura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takanashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamagata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamanouchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mizuguchi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes</article-title>
          <source>Brain Dev</source>
          <year>2012</year>
          <volume>34</volume>
          <issue>5</issue>
          <fpage>337</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1016/j.braindev.2011.07.012</pub-id>
          <pub-id pub-id-type="pmid">21924570</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyata</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tanuma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Imamura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takanashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Okumura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kashii</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tomita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kumada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)</article-title>
          <source>Brain Dev</source>
          <year>2012</year>
          <volume>34</volume>
          <issue>2</issue>
          <fpage>124</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="doi">10.1016/j.braindev.2011.04.004</pub-id>
          <pub-id pub-id-type="pmid">21576007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="other">Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection (1999). Pediatrics 103 (4 Pt 1):843-852</mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prilipko</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Delavelle</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lazeyras</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Seeck</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review</article-title>
          <source>Epilepsia</source>
          <year>2005</year>
          <volume>46</volume>
          <issue>10</issue>
          <fpage>1633</fpage>
          <lpage>1636</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2005.00256.x</pub-id>
          <pub-id pub-id-type="pmid">16190935</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheu</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Lue</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Tsay</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis</article-title>
          <source>Cytokine</source>
          <year>2006</year>
          <volume>36</volume>
          <issue>5&#x2013;6</issue>
          <fpage>276</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cyto.2007.02.006</pub-id>
          <pub-id pub-id-type="pmid">17374489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takanashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Barkovich</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Oba</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsukahara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimono</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ichiyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Taoka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sohma</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Yoshikawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kohno</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Clinically mild encephalitis/encephalopathy with a reversible splenial lesion</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>63</volume>
          <issue>10</issue>
          <fpage>1854</fpage>
          <lpage>1858</lpage>
          <pub-id pub-id-type="doi">10.1212/01.WNL.0000144274.12174.CB</pub-id>
          <pub-id pub-id-type="pmid">15557501</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takanashi</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Two newly proposed infectious encephalitis/encephalopathy syndromes</article-title>
          <source>Brain Dev</source>
          <year>2009</year>
          <volume>31</volume>
          <issue>7</issue>
          <fpage>521</fpage>
          <lpage>528</lpage>
          <pub-id pub-id-type="doi">10.1016/j.braindev.2009.02.012</pub-id>
          <pub-id pub-id-type="pmid">19339128</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takanashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Neonate showing reversible splenial lesion</article-title>
          <source>Arch Neurol</source>
          <year>2005</year>
          <volume>62</volume>
          <issue>9</issue>
          <fpage>1481</fpage>
          <lpage>1482</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.62.9.1481</pub-id>
          <pub-id pub-id-type="pmid">16157763</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takanashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shirai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sugawara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Obonai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Terada</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS)</article-title>
          <source>J Neurol Sci</source>
          <year>2012</year>
          <volume>315</volume>
          <issue>1&#x2013;2</issue>
          <fpage>167</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jns.2011.11.022</pub-id>
          <pub-id pub-id-type="pmid">22129937</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pierangeli</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Papalardo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ansari</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity</article-title>
          <source>Arthritis Rheum</source>
          <year>2010</year>
          <volume>62</volume>
          <issue>7</issue>
          <fpage>2064</fpage>
          <lpage>2072</lpage>
          <pub-id pub-id-type="pmid">20201076</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
